Short‐term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device
ESC Heart Failure, 2023 Aims We sought to investigate the outcomes of heart transplant patients supported with Impella 5.5 temporary mechanical circulatory support. Methods and results Patient demographics, perioperative data, hospital timeline, and haemodynamic parameters were
Osama Haddad +10 more
doaj +1 more source
Coronary angiography in heart failure: when and why? Uncertainty reigns [PDF]
, 2017 No abstract ...
Petrie, Mark C., Rocchiccioli, Paul
core +1 more source
Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
Journal of Cardiothoracic Surgery, 2022 Background Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. Case presentation We report three cases of successful intensive treatment by Impella of FM without any complications.
Takayuki Hori +3 more
doaj +1 more source
Transaxillary implantation of the Impella CP mechanical circulatory support device as a bridge to heart transplant: first experience in Spain [PDF]
, 2017 Carta ...
Couto-Mallón, David +5 more
core +2 more sources
Displacement of impella post chest compressions
Heart Views, 2014 The Impella is a left ventricular assist device which is implanted via the transcutaneous femoral route and is placed across the aortic valve into the left ventricle.
Sourabh Aġġarwal, Susan Bannon
doaj +1 more source
Right ventricular failure: Current strategies and future development
Frontiers in Cardiovascular Medicine, 2023 Right heart failure can be defined as a clinical syndrome consisting of signs and symptoms of heart failure resulting from right ventricular dysfunction. Function is normally altered due to three mechanisms: (1) pressure overload (2) volume overload, or (
María Monteagudo-Vela +7 more
doaj +1 more source
PLoS ONE, 2020 BackgroundIn selected patients with an acute myocardial infarction (AMI) complicated by Cardiogenic shock (CS), mechanical circulatory support with Impella may be beneficial, although conclusive evidence is still lacking.
Veemal V Hemradj +17 more
doaj +1 more source
Impella as unloading strategy during VA-ECMO: systematic review and meta-analysis
Reviews in Cardiovascular Medicine, 2021 Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used as mechanical circulatory support in cardiogenic shock (CS). It restores peripheral perfusion, at the expense of increased left ventricle (LV) afterload.
Francesca Fiorelli +1 more
doaj +1 more source
Current state-of-the-art of device therapy for advanced heart failure [PDF]
, 2014 Heart failure remains one of the most common causes of morbidity and mortality worldwide. The advent of mechanical circulatory support devices has allowed significant improvements in patient survival and quality of life for those with advanced or end ...
Lee, Lawrence S., Shekar, Prem S.
core +2 more sources
Heart Rate Variability: A possible machine learning biomarker for mechanical circulatory device complications and heart recovery [PDF]
, 2020 Cardiovascular disease continues to be the number one cause of death in the United States, with heart failure patients expected to increase to \u3e8 million by 2030.
Aras, Shravan +2 more
core +1 more source